Literature DB >> 189893

Prospective study of non-infiltrating carcinoma of the breast.

R Ashikari, A G Huvos, R E Snyder.   

Abstract

A long-term prospective study of non-infiltrating breast carcinoma is being carried out in order to study the natural history and proper management of such lesions with particular interest in patients treated solely by local excision. During an 11-year period, 175 patients with lobular Ca in situ and intraductal Ca have been followed. None has developed recurrent disease including 18 undergoing wide local excision only. Histologic examination revealed that 36% of mastectomy specimens showed multifocal lesions, whereas only one of the patients treated by wide local excision had more than one microscopic focus. For these reasons total mastectomy is recommended as the treatment of non-infiltrating breast carcinoma. Subsequent development of contralateral cancer has occurred in ten patients.

Entities:  

Mesh:

Year:  1977        PMID: 189893     DOI: 10.1002/1097-0142(197702)39:2<435::aid-cncr2820390211>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Spread to the nipple and areola in carcinoma of the breast.

Authors:  J A Andersen; R M Pallesen
Journal:  Ann Surg       Date:  1979-03       Impact factor: 12.969

Review 2.  Benign breast disease in the postmenopausal woman.

Authors:  J E Devitt
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

Review 3.  Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.

Authors:  Hilary M Shapiro-Wright; Thomas B Julian
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 4.  [Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated?].

Authors:  F K Böhler; H Eiter; W Rhomberg
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

5.  Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer.

Authors:  J D Iglehart; B J Kerns; G Huper; J R Marks
Journal:  Breast Cancer Res Treat       Date:  1995-06       Impact factor: 4.872

6.  Management of ductal carcinoma in situ of the breast.

Authors:  J V Reynolds; J P Sweeney; N Nolan; A Korebrits; M J Duffy; E W McDermott; N J O'Higgins
Journal:  Ir J Med Sci       Date:  1993-02       Impact factor: 1.568

7.  Possible immunological implications of an association between the stages of first and second independent breast cancers.

Authors:  M M Black; B F Hankey; J L Aron; P C Prorok
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

8.  Duct carcinoma in situ: predictors of local recurrence and progression in patients treated by surgery alone.

Authors:  P Price; H D Sinnett; B Gusterson; G Walsh; R P A'Hern; J A McKinna
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.